New Strategies to Assess Anal Cancer Risk In Women
Condition(s):Human Immunodeficiency Virus (HIV); Human Papillomavirus (HPV)Last Updated:November 6, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Human Immunodeficiency Virus (HIV); Human Papillomavirus (HPV)Last Updated:November 6, 2019Completed
Condition(s):Anal Intraepithelial Neoplasia 2; Anal Intraepithelial Neoplasia 1; Anal Cancer; High-Risk CancerLast Updated:March 26, 2024Recruiting
Condition(s):Rectal or Anal CancerLast Updated:July 5, 2023Active, not recruiting
Condition(s):Anal Cancer; Anal Carcinoma; Anal Squamous Cell CarcinomaLast Updated:September 25, 2023Recruiting
Condition(s):Anal Cancer; Quality of LifeLast Updated:February 9, 2021Completed
Condition(s):Anal Cancer; Locally Advanced Squamous Cell Carcinoma; Oligometastatic Disease; Circulating Tumor Cell; Human Papilloma VirusLast Updated:February 10, 2022Recruiting
Condition(s):Anal CancerLast Updated:February 11, 2020Terminated
Condition(s):Anal CancerLast Updated:January 30, 2018Unknown status
Condition(s):Anal CancerLast Updated:June 23, 2011Completed
Condition(s):Anal Cancer; Quality of Life; ChemoradiationLast Updated:January 3, 2019Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.